Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$0.35 - $20.75 $5,250 - $311,250
-15,000 Reduced 6.92%
201,704 $80,000
Q2 2022

Aug 11, 2022

BUY
$1.12 - $2.18 $4,480 - $8,720
4,000 Added 1.88%
216,704 $280,000
Q1 2022

May 11, 2022

SELL
$1.63 - $3.63 $1,300 - $2,896
-798 Reduced 0.37%
212,704 $570,000
Q4 2021

Feb 14, 2022

SELL
$2.25 - $4.11 $4,495 - $8,211
-1,998 Reduced 0.93%
213,502 $480,000
Q2 2021

Aug 12, 2021

BUY
$4.83 - $9.67 $1.04 Million - $2.08 Million
215,500 New
215,500 $1.07 Million

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Bard Associates Inc Portfolio

Follow Bard Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bard Associates Inc with notifications on news.